Citeline

Citeline

Q2 2021 Clinical Trials and the COVID-19 Vaccine Pulse Report

The goal of our second Clinical Trials & the COVID-19 Vaccine Pulse Report is to uncover who is still hesitant to take a vaccine, and what public health experts from pharma to the U.S. government can do to turn the tide.

Topic Coronavirus Clinical Trials

Citeline, Trialtrove

2020 Completed Trials A Bumpy Road for Industry Sponsored Clinical Studies

Over the past five years, our analysis of completed trials consistently observed growth trends.

Topic Coronavirus Clinical Trials

Topic Cardiovascular Coronavirus

Pharmaprojects, Citeline

Pharma R&D Annual Review & NAS Supplement 2021

Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible? 

Topic Clinical Trials Diseases Drug Review

Citeline

Clinical Trial Webinar Series

Learn about the latest trends affecting biopharma R&D including, study diversity & transparency, predictive feasibility and more...

Topic Coronavirus Clinical Trials BioPharmaceutical

Citeline

Citeline Study Feasibility is launching soon!

Improve your clinical trial decisions and cycle times

Topic Clinical Trials

Citeline, Sitetrove, Trialtrove

Achieve Clinical Trial Success with Sitetrove and Trialtrove

Even one misstep in your clinical trials strategy or execution can cost your company millions. Save time and cost with the trusted source for global investigator and site intelligence and global pharmaceutical clinical trial intelligence by subscribing to Sitetrove and Trialtrove.

Topic Clinical Trials Coronavirus

Citeline

Clinical Trials & the COVID-19 Vaccine

Informa Pharma Intelligence’s Pulse Report

Topic Coronavirus Clinical Trials

Citeline

Exploring Basket and Umbrella Oncology Trials

To increase flexibility and efficiency in drug development, master protocols have emerged as an innovative clinical trial design, including basket and umbrella trials. Learn more about how these approaches are being used within oncology research through an overview of the clinical landscape, trial outcomes and trends.

Topic Drug Development Landscape

Citeline

Depression New Insights Shifting the Treatment Paradigm Whitepaper

Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.

Topic Drug Development Landscape

Topic Coronavirus

Citeline

Clinical Trials State of the Industry Report 2019

KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables. The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.

Topic Drug Development Landscape

Citeline

Breast Cancer Clinical Landscape and Recent Trends Whitepaper

Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.

Topic Cancer Clinical Trials Research & Development

Citeline

A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis

The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the active oncology therapeutic area. Industry-sponsored clinical trials across all oncology indications covered by Informa Pharma Intelligence’s Trialtrove were assessed, comparing metrics by company size based on pharma sales, and the identical benchmarks for breast cancer and rare cancers were also analyzed.

Topic Clinical Trials Cancer

Citeline

2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity

Tap into expert analysis of the trends and what they mean for the future of pharma with Citeline’s latest whitepaper, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity.

Topic Clinical Trials